Beacon Capital Management Inc (Ohio)’s iShares Biotechnology ETF IBB Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-450	Closed	-$39K	–	175
2016 Q1	$39K	Hold	450	–	–	﹤0.01%	73
2015 Q4	$51K	Hold	450	–	–	﹤0.01%	72
2015 Q3	$45K	Hold	450	–	–	﹤0.01%	78
2015 Q2	$55K	Sell	450 -30	-6%	-$3.59K	﹤0.01%	76
2015 Q1	$55K	Buy	480 +30	+7%	+$3.31K	0.01%	79
2014 Q4	$46K	Hold	450	–	–	0.01%	84
2014 Q3	$41K	Hold	450	–	–	0.01%	96
2014 Q2	$39K	Hold	450	–	–	0.01%	100
2014 Q1	$35K	Hold	450	–	–	0.01%	101
2013 Q4	$34K	Buy	+450	New	+$31.9K	0.01%	96

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s IBB Position: Q2 2016 in Review

Beacon Capital Management Inc (Ohio) sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 450 shares — an estimated $39K sold.

Beacon Capital Management Inc (Ohio) first reported a position in IBB in Q4 2013 and held it in 10 quarters. The position peaked at $55K in Q2 2015. 429 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

Beacon Capital Management Inc (Ohio) reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
Beacon Capital Management Inc (Ohio) sold 450 iShares Biotechnology ETF shares in Q2 2016, an estimated $39K.
Beacon Capital Management Inc (Ohio) first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 10 quarters.
Beacon Capital Management Inc (Ohio)'s iShares Biotechnology ETF position peaked at $55K in Q2 2015.
429 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q2 2016, filed 8 Jul 2016.